DebasishBanerjee United KingdomSt George's University Hospital NHS Foundation Tr

Debasish Banerjee is the Clinical Lead of the Department of Renal Medicine and Transplantation and Co-Director of the Translational and Clinical Research Institute at St George's University Hospitals NHS Foundation Trust, with special interest in cardiovascular complications of chronic kidney disease. He established the multidisciplinary CKD-heart failure clinic and Cardio-Kidney-Metabolic clinic in St George’s Hospital. He is a Professor of Renal Medicine and Quality Lead for the MBBS Program at City St George's, University of London.

Institution

Day 1 - Sunday April 14, 2024

Time	Session

9 a.m. 10:30 a.m.	Innovations in Transplantation CHAL01 Gervasio Soler-Pujol Chairperson gsolerpujol@gmail.comMD MarioSchiffer Chairperson mario.schiffer@uk-erlangen.deGermanyUniversity hospital Erlangen Update in Robotic Kidney Transplantation RajeshSivaprakasam Speaker rajesh.sivaprakasam@nhs.netUnited Kingdom Progress in Xenotransplantation MeganSykes Speaker ms3976@cumc.columbia.eduUnited States Antigen-specific Chimeric Antigen Receptor Regulatory T Cells for Use in Solid Organ Transplantation CarolineLamarche Speaker caroline.lamarche.1@umontreal.caCanadaUniversité de Montréal Post Transplant TMA-pathogenesis and Management LilianMonteiro P. Palma Speaker lilian.palma@icloud.comBrazilState University of Campinas Q and A Hall A
10:30 a.m. 11 a.m.	Hitting the Four Hits: The Potential of Dual BAFF/APRIL Inhibition in IgA Nephropathy SPOT-O3 Jonathan Barret Spotlight Speaker jb81@leicester.ac.ukUnited KingdomUniversity of Leicester, Leicester, UK Spotlight Stage 1 (exhibition hall)
11 a.m. 12 p.m.	Plenary Session 2: CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? (Obiageli Eunice Nnodu, Nigeria) PL2 AgnesFogo Chairperson agnes.fogo@vanderbilt.eduUnited States GuillermoRosa Diez Chairperson guillermo.rosadiez@hospitalitaliano.org.arArgentinaHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of Nephrology My Story VictoriaGray Speaker vwright_03@yahoo.comUnited States CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? Hugh de Wardener Lecture Obiageli EuniceNnodu Speaker oennodu@gmail.comNigeriaUniversity of Abuja Hall A
12:15 p.m. 1:15 p.m.	Transplant Tourism in My Clinic: What Should I Do? ISN-DICG Joint Session CHAL1001 Domingo Casadei Chairperson drdomingocasadei@gmail.com VivekanandJha Chairperson vjha@georgeinstitute.org.inIndiaGeorge Institute for Global Health India How to Achieve Transparent and Regulated Organ Donation and Transplantation Maria AmaliaMatamoros Speaker amatamoros@cehcr.comCosta RicaCaja Costarricense del Seguro social Non-resident Foreigners in Argentina: Legal Framework to Prevent Transplant Tourism LilianaBisigniano Speaker lbisigniano@incucai.gov.arArgentinaLiliana Bisigniano MD How to Handle Cases of Presumed Transplant Tourism KenSakai Speaker kensakai@med.toho-u.ac.jpJapanDepartment of Nephrology, Toho University Omori Medical Center Q and A Hall C1
2:45 p.m. 3:30 p.m.	What is ongoing in CKDu around the world? - CKDU interactive discussions (ISN i3C) SPOT-06 ErangaWijewickrama Spotlight Chairperson erangasw@clinmed.cmb.ac.lkSri LankaFaculty of Medicine, University of Colombo Jose VicenteSanchez Polo Spotlight Chairperson visanpolo@gmail.comGuatemalaRenal Division Social Security Institute. Nephrology Residence Program Coordinator, San Carlos University School of Medicine. Latin-American Society Of Nephrology (SLANH) Magdalena Madero Spotlight Speaker madero.magdalena@gmail.comMexicoChief of Nephrology, Instituto Nacional de Cardiol VivekanandJha Spotlight Speaker vjha@georgeinstitute.org.inIndiaGeorge Institute for Global Health India NishanthaNanyakkara Spotlight Speaker nishantha4313@gmail.comSri Lanka Spotlight Stage 1 (exhibition hall)
3 p.m. 4 p.m.	Cardiorenal Syndrome: Updates in the Pathophysiology and State-of-the-Art Treatment IK01 FelipeInserra Chairperson felipe.inserra@gmail.comArgentina YelenaDrexler Chairperson yrd6@miami.eduUnited StatesUniversity of Miami Miller School of Medicine New Insights into the Mechanisms of Kidney Injury in the CRS WendyMccallum Speaker wmccallum@tuftsmedicalcenter.orgUnited States Novel Pharmacological Treatments of the CRS MarkSarnak Speaker msarnak@tuftsmedicalcenter.orgUnited StatesTufts Medical Center Device-related Treatment for CRS ClaudioRonco Speaker cronco@goldnet.itItalyInternational Renal Research Institute of Vicenza Q and A Hall D
4 p.m. 4:30 p.m.	Potential Role of Anti-CD38 Therapy in Autoimmune Kidney Diseases like Lupus Nephritis SPOT-07 BradRovin Spotlight Speaker rovin.1@osu.eduUnited StatesThe Ohio State University UptalPatel Spotlight Speaker uptal@hibio.comUnited States Spotlight Stage 1 (exhibition hall)
4:30 p.m. 5:30 p.m.	New Developments in CKD Epidemiology Research IK1001 MaartenTaal Chairperson maarten.taal1@nhs.netUnited KingdomUniversity of Nottingham RobertoPecoits Filho Chairperson roberto.pecoits@arborresearch.orgUnited StatesArbor Research Collaborative for Health Big Data Lab LAB-01 Patient-reported Outcome Measures: How Do Patients Experience CKD? AdeeraLevin Speaker alevin@providencehealth.bc.caCanadaUniversity of British Columbia and Providence Health Care Trial Simulation Using Observational Data AngeloKaraboyas Speaker angelo.karaboyas@arborresearch.orgUnited StatesArbor Research Collaborative for Health Using Routinely Collected Big Datasets for Clinical Research in CKD: Opportunities and Challenges DorotheaNitsch Speaker dorothea.nitsch@lshtm.ac.ukUnited KingdomLondon School of Hygiene & Tropical Medicine Q and A Hall C4

Day 2 - Monday April 15, 2024

Time	Session

12:15 p.m. 1:15 p.m.	The Journey of a Patient with Kidney and Cardiovascular Diseases: From Detection to Referral to Co-management IK1002 RobertoPecoits Filho Chairperson roberto.pecoits@arborresearch.orgUnited StatesArbor Research Collaborative for Health Challenges in the Early Detection and Management of a Patient at the Interface of Kidney and Heart Disease MarisolTorres Toledano Speaker torres.t.marisol@gmail.comMexicoIMSS, MEXICO Co-management of Patients With Cardio-Kidney Diseases: Let DebasishBanerjee Speaker dbanerje@sgul.ac.ukUnited KingdomSt George's University Hospital NHS Foundation Tr Co-management of Patients With Cardio-Kidney Diseases: Let CharlesHerzog Speaker Charles.Herzog@cdrg.orgUnited StatesISN and Hennepin Healthcare/University of Minnes Q and A Hall C1

Time

Session

12:15 p.m.

1:15 p.m.

The Journey of a Patient with Kidney and Cardiovascular Diseases: From Detection to Referral to Co-management

IK1002

RobertoPecoits Filho Chairperson roberto.pecoits@arborresearch.orgUnited StatesArbor Research Collaborative for Health

Challenges in the Early Detection and Management of a Patient at the Interface of Kidney and Heart Disease

MarisolTorres Toledano Speaker torres.t.marisol@gmail.comMexicoIMSS, MEXICO
Co-management of Patients With Cardio-Kidney Diseases: Let

DebasishBanerjee Speaker dbanerje@sgul.ac.ukUnited KingdomSt George's University Hospital NHS Foundation Tr
Co-management of Patients With Cardio-Kidney Diseases: Let

CharlesHerzog Speaker Charles.Herzog@cdrg.orgUnited StatesISN and Hennepin Healthcare/University of Minnes
Q and A

Hall C1

Day 3 - Tuesday April 16, 2024

Time	Session

9 a.m. 10 a.m.	Type 2 Diabetes in Kidney Disease: Recent Updates and Best Practices for Detection and Treatment LF1002 DebasishBanerjee Chairperson dbanerje@sgul.ac.ukUnited KingdomSt George's University Hospital NHS Foundation Tr MegJardine Chairperson meg.jardine@sydney.edu.auAustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia Setting the Scene MegJardine Speaker meg.jardine@sydney.edu.auAustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia DM and CKD: Which Treatment Should I Use for Different Populations? KatherineTuttle Speaker Katherine.Tuttle@providence.orgUnited StatesUniversity of Washington School of Medicine, Division of Nephrology How to Design Studies on Answering Unanswered Questions VladoPerkovic Speaker vlado.perkovic@unsw.edu.auAustraliaUniversity of New South Wales, Sydney, Australia The Effect of SGLT2 Inhibitors in Patients with Chronic Kidney Disease, With or Without Type 2 Diabetes DavidWheeler Speaker d.wheeler@ucl.ac.ukUnited KingdomUniversity College London Q and A Hall C4

Time

Session

9 a.m.

10 a.m.

Type 2 Diabetes in Kidney Disease: Recent Updates and Best Practices for Detection and Treatment

LF1002

DebasishBanerjee Chairperson dbanerje@sgul.ac.ukUnited KingdomSt George's University Hospital NHS Foundation Tr

MegJardine Chairperson meg.jardine@sydney.edu.auAustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia

Setting the Scene

MegJardine Speaker meg.jardine@sydney.edu.auAustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia
DM and CKD: Which Treatment Should I Use for Different Populations?

KatherineTuttle Speaker Katherine.Tuttle@providence.orgUnited StatesUniversity of Washington School of Medicine, Division of Nephrology
How to Design Studies on Answering Unanswered Questions

VladoPerkovic Speaker vlado.perkovic@unsw.edu.auAustraliaUniversity of New South Wales, Sydney, Australia
The Effect of SGLT2 Inhibitors in Patients with Chronic Kidney Disease, With or Without Type 2 Diabetes

DavidWheeler Speaker d.wheeler@ucl.ac.ukUnited KingdomUniversity College London
Q and A

Hall C4